Associate Director, Strategic Pricing, International Market Access & Pricing

Core Job Responsibilities
Strategic Pricing
- Lead pricing analytics and presentations for the impact of global pricing reforms (including MFN-based policies) across the international therapeutics portfolio (in-market and pipeline; varying reimbursement structures and market access challenges across geographies).
- Build and maintain pricing models to simulate the impact of International Reference Pricing (IRP) and Most Favored Nations (MFN) clauses on global revenue.
- Lead MFN discussions with senior management ad hoc and during key planning cycles.
- Optimize timing and order of product launches across international markets to minimize “price erosion” from cross-border reference benchmarking.
- Develop “What-If” scenario planning for entry into new therapeutic areas; forecast long-term price ceilings using International Price Referencing competitor benchmarks.
- Ensure accuracy of the global pricing database to prevent “cascading” pricing errors that could trigger involuntary price cuts in linked markets.
- Lead strategic discussions for MFN mitigation / revenue maximization with the International and Global Pricing Council.
- Partner with Legal, Government Affairs, Market Access, Finance, and other INTL functions to determine impacts of changes in US & INTL rules and regulations.
- Serve as MFN Pricing subject matter expert to Strategic Pricing Directors on an ad hoc basis.

Policy-Driven Strategic Pricing
- Assess and quantify financial impact from evolving healthcare policies (including International Reference Pricing, US legislative changes, and Prescription Drug Affordability Board requests).
- Anticipate and analyze implications of healthcare policy shifts (e.g., CMS, G-BA, MHML, CADTH, HAS) and government initiatives (including Executive Orders) on INTL pricing strategies and business practices.
- Develop and implement recommendations to optimize pricing/sales impact in dynamic policy environments.
- Build and maintain partnerships with cross-functional teams (Market Access, BESD, Brand teams, US Pricing, etc.) to align and execute pricing strategies.
- Synthesize complex data into clear, actionable reports for Business Evolution and Strategy Development CoE.
- Present findings and recommendations to senior management (including C-Suite) to support evidence-based decisions and long-term planning.
- Drive continuous improvement using data analytics and scenario planning (including futureproof alternative solutions).
- Monitor global trends and best practices in healthcare policy and pricing to identify opportunities and risks.

Influencing Without Authority in Pricing Analytics
- Lead adoption of new pricing analytics tools/methodologies across international by demonstrating business/market “value-add.”
- Simplify high-complexity pricing analytics into “board-ready” visualizations for rapid decision-making.
- Build and maintain relationships with stakeholders across International Market Access and Pricing, INTL Finance, Business Evolution & Strategy Development, US Finance/Pricing, and US Market Access.
- Act as a consultative resource for pricing leads across business units to promote rigorous, policy-aligned pricing thinking.

Qualifications
- Bachelor’s degree in accounting or finance; 10+ years of related experience (ideally in pharmaceutical industry).
- CPA/MBA preferred.
- Forecasting and Market Access Finance experience required.
- Ability to synthesize new topics and quickly achieve subject matter expertise.
- Ability to lead without authority.
- Experience leading/motivating a team in a dynamic environment preferred.
- Independent thinker; works cross-functionally with appropriate leadership.
- High competence, confidence, and credibility.
- Ability to make decisions with incomplete data and under ambiguity/uncertainty.
- Experience supporting GM/VP-level planning activities and monitoring financial results/targets preferred.
- Excellent oral/written communication and presentation skills.
- Ability to manage workload and meet critical deadlines under challenging time constraints.